Metabolic control of outpatients with T1DM Several groups from Italy, Spain and the UK have reported that patients with T1DM and without COVID-19 have shown no deteriorations in glycaemic control, and often even show improvements in control, during the pandemic compared with a control period before the pandemic 131,132,133
"It actually changes peoples moles in general
Could these drugs have other uses
The presence of GLP-1 (GLP-1R) and GIP receptors (GIP-R) suggest direct interaction of these agents with EAT
They are not prescription drugs, do not contain GLP-1 agonists such as semaglutide or tirzepatide, and are not intended to diagnose, treat, cure, or prevent any disease